Related Experiment Video
Updated: May 21, 2026

Establishment of Proliferative Tetraploid Cells from Nontransformed Human Fibroblasts
Published on: January 8, 2017
Tumor suppressor TAp73 gene specifically responds to deregulated E2F activity in human normal fibroblasts
Eiko Ozono1, Hideyuki Komori, Ritsuko Iwanaga
1Department of Molecular Virology, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8510, Japan.
Abstract:
Discrimination of oncogenic growth signals from normal growth signals is crucial for tumor suppression. The transcription factor E2F, the main target of pRB, plays central role in cell proliferation by activating growth-promoting genes. E2F also plays an important role in tumor suppression by activating growth-suppressive genes such as pro-apoptotic genes. The regulatory mechanism of the latter genes is not known in detail, especially in response to normal and oncogenic growth signals. E2F is physiologically activated by growth stimulation through phosphorylation of pRB. In contrast, upon dysfunction of pRB, a major oncogenic change, E2F is activated out of control by pRB, generating deregulated E2F activity. We show here that the tumor suppressor TAp73 gene, which can induce apoptosis independently of p53, responds to deregulated E2F activity, but not to physiological E2F activity induced by growth stimulation in human normal fibroblasts. We identified E2F-responsive elements (ERE73s) in TAp73 promoter that can specifically sense deregulated E2F activity. Moreover, RB1-deficient cancer cell lines harbored deregulated E2F activity that activated ERE73s and the TAp73 gene, which were suppressed by re-introduction of pRB. These results underscore the important role of deregulated E2F in activation of the TAp73 gene, a component of major intrinsic tumor suppressor pathways.
Insights
Deregulated E2F activity, not normal growth signals, activates the tumor suppressor TAp73 gene. This occurs through specific E2F-responsive elements in the TAp73 promoter, highlighting a key tumor suppression pathway.
Area of Science:
- Molecular Biology
- Cancer Biology
- Cell Cycle Regulation
Background:
- Tumor suppression relies on distinguishing oncogenic from normal growth signals.
- The transcription factor E2F, regulated by pRB, controls cell proliferation and tumor suppression.
- The precise regulation of E2F targets, particularly growth-suppressive genes, remains incompletely understood.
Purpose of the Study:
- To investigate the differential response of the TAp73 gene to physiological versus deregulated E2F activity.
- To identify specific regulatory elements mediating TAp73 activation by aberrant E2F.
- To elucidate the role of deregulated E2F in activating TAp73 within the context of RB1 deficiency.
Main Methods:
- Analysis of TAp73 promoter activity in human normal fibroblasts under varying E2F activation conditions.
- Identification and characterization of E2F-responsive elements (ERE73s) within the TAp73 promoter.
- Assessment of ERE73s and TAp73 gene activation in RB1-deficient cancer cell lines with and without pRB re-introduction.
Main Results:
- The tumor suppressor TAp73 gene specifically responds to deregulated E2F activity, not physiological E2F activation.
- Novel E2F-responsive elements (ERE73s) were identified in the TAp73 promoter, capable of sensing deregulated E2F.
- RB1-deficient cancer cells exhibited deregulated E2F activity, leading to ERE73s and TAp73 activation, which was reversed by pRB re-introduction.
Conclusions:
- Deregulated E2F activity is a critical factor in activating the TAp73 gene.
- The TAp73 gene and its promoter elements (ERE73s) function as sensors of aberrant E2F signaling.
- These findings highlight the significance of deregulated E2F in activating TAp73, a crucial component of intrinsic tumor suppressor pathways.
More Related Videos
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Related Concept Videos
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Negative Regulator Molecules
mTOR Signaling and Cancer Progression
The mTOR pathway or the...